TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,842.87−0.15%FTSE ADX9,789.92+0.07%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,034.17+0.04%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 352.80+0.23%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.55+0.03%Gold$4,129.46−0.27%Brent$109.91+0.63%BTC$81,641.10−0.25%ETH$2,392.58−0.52%DFM General5,842.87−0.15%FTSE ADX9,789.92+0.07%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,034.17+0.04%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 352.80+0.23%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.55+0.03%Gold$4,129.46−0.27%Brent$109.91+0.63%BTC$81,641.10−0.25%ETH$2,392.58−0.52%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Alpha Cognition Inc · Overview · TradingHolo

Markets › United States › NAS › ACOG

A

Alpha Cognition Inc

NAS:ACOGHealthcarenasdaq_composite

$8.50+3.79%At closeAt close · Tue 20 Oct · ≈ AED 31.22 · Market cap $185.11M · Next earnings Thu 12 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+3.8%

1M

−3.7%

3M

+7.7%

6M

+23.4%

1Y

+20.4%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

ACOG +3.79% today

✦ This week in three lines

No written digest yet for ACOG. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−9.0× vs −1.7×

Price / Book vs sector3.0× vs 2.0×

Price / Sales vs sector18.1× vs 3.9×

Price / Free cash flow vs sector−9.0× vs −1.5×

Forecasts

5 buy0 hold0 sell5 analysts

Average target$18.50 +117.6%

Analysts2

EPS surprises, last 84 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All ACOG news →

BUAlpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®

BusinessWire · 7 d ago

TRAlpha Cognition Inc. (ACOG) USPTO Publishes ZUNVEYL Manufacturing Patent Application

TradingView · 7 d ago

BUAlpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress

BusinessWire · 14 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$185.11M

P/E−9.0×

Dividend yield0.0%

52-week range$4.50 – $10.14

Avg volume (20d)96,070

Shares outstanding15,531,300

Beta2.23

Short interest2.3% of float

Next earningsThu 12 Nov

Radar Score

47

Value39

Quality38

Momentum67

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×+1.36%